HOX transcription factors and the prostate tumor microenvironment

Abstract

It is now well established that the tumor microenvironment plays an essential role in the survival, growth, invasion, and spread of cancer through the regulation of angiogenesis and localized immune responses. This review examines the role of the HOX genes, which encode a family of homeodomain-containing transcription factors, in the interaction between prostate tumors and their microenvironment. Previous studies have established that HOX genes have an important function in prostate cancer cell survival in vitro and in vivo, but there is also evidence that HOX proteins regulate the expression of genes in the cancer cell that influence the tumor microenvironment, and that cells in the microenvironment likewise express HOX genes that confer a tumor-supportive function. Here we provide an overview of these studies that, taken together, indicate that the HOX genes help mediate cross talk between prostate tumors and their microenvironment.

Keywords

Prostate cancer / tumor microenvironment / HOX / PBX / metastasis / angiogenesis

References

[1] Dai J,Roca H,Zhang J,Keller ET.Immune mediators in the tumor microenvironment of prostate cancer..Chin J Cancer2017;36:29 PMCID:PMC5351274

[2] Huang Y,Righi E,Ancukiewicz M,Santosuosso M,Martin MR,Leblanc P,Huang P,Fukumura D,Poznansky MC.Vascular normalizing doses of antiangiogenic treatment reprogram the immunosuppressive tumor microenvironment and enhance immunotherapy..Proc Natl Acad Sci U S A2012;109:17561-6 PMCID:PMC3491458

[3] Niu YN.Stroma-epithelium crosstalk in prostate cancer..Asian J Androl2009;11:28-35 PMCID:PMC3735213

[4] Yoneda T.Crosstalk between cancer cells and bone microenvironment in bone metastasis..Biochem Biophys Res Commun2005;328:679-87

[5] Mallo M,Deschamps J.Hox genes and regional patterning of the vertebrate body plan..Dev Biol2010;344:7-15 PMCID:PMC2909379

[6] Gehring WJ.Homeo boxes in the study of development..Science1987;236:1245-52

[7] Holland PW,Bruford EA.Classification and nomenclature of all human homeobox genes..BMC Biol2007;5:47 PMCID:PMC2211742

[8] Platais C,Darda L,Morgan R.The role of HOX genes in head and neck squamous cell carcinoma..J Oral Pathol Med2016;45:239-47

[9] Longobardi E,Mateos D,Torres M.Biochemistry of the tale transcription factors PREP, MEIS, and PBX in vertebrates..Dev Dyn2014;243:59-75 PMCID:PMC4232920

[10] Allen TD,Hawley TS.TALE homeoproteins as HOX11-interacting partners in T-cell leukemia..Leuk Lymphoma2000;39:241-56

[11] Brendolan A,Salsi V,Quaggin S,Cleary ML.A Pbx1-dependent genetic and transcriptional network regulates spleen ontogeny..Development2005;132:3113-26

[12] Piper DE,Chang CP,Wolberger C.Structure of a HoxB1-Pbx1 heterodimer bound to DNA: role of the hexapeptide and a fourth homeodomain helix in complex formation..Cell1999;96:587-97

[13] Williams TM,Innis JW.Range of HOX/TALE superclass associations and protein domain requirements for HOXA13:MEIS interaction..Dev Biol2005;277:457-71

[14] Di-Poi N,Radtke F.Additive and global functions of HoxA cluster genes in mesoderm derivatives..Dev Biol2010;341:488-98

[15] Kyba M,Daley GQ.HoxB4 confers definitive lymphoid-myeloid engraftment potential on embryonic stem cell and yolk sac hematopoietic progenitors..Cell2002;109:29-37

[16] Lebert-Ghali CE,Dickson GJ,Sauvageau G.HoxA cluster is haploinsufficient for activity of hematopoietic stem and progenitor cells..Exp Hematol2010;38:1074-86.e1-5

[17] Xu B,Bu Z,Jin L,Zhang H.Regulation of endometrial receptivity by the highly expressed HOXA9, HOXA11 and HOXD10 HOX-class homeobox genes..Hum Reprod2014;29:781-90

[18] Rux DR,Swinehart IT,Schlientz AJ,Goldstein SA,Lucas D.Regionally restricted Hox function in adult bone marrow multipotent mesenchymal stem/stromal cells..Dev Cell2016;39:653-66

[19] Alharbi RA,Pandha HS.The role of HOX genes in normal hematopoiesis and acute leukemia..Leukemia2013;27:1000-8

[20] Shah N.The Hox genes and their roles in oncogenesis..Nat Rev Cancer2010;10:361-71

[21] Asuthkar S,Lebedeva T,Estes N,Rao JS.Multifunctional roles of urokinase plasminogen activator (uPA) in cancer stemness and chemoresistance of pancreatic cancer..Mol Biol Cell2013;24:2620-32 PMCID:PMC3756915

[22] Shang L,Awgulewitsch A.Hoxc12 expression pattern in developing and cycling murine hair follicles..Mech Dev2002;113:207-10

[23] Morgan R,Hunter KD,Pandha HS.Targeting HOX/PBX dimers in cancer..Oncotarget2017;8:32322-31

[24] Morgan R,Harrington KJ,Gillett C,Pandha HS.Targeting the HOX/PBX dimer in breast cancer..Breast Cancer Res Treat2012;136:389-98

[25] Morgan R,Harrington KJ,Michael A.Targeting HOX transcription factors in prostate cancer..BMC Urol2014;14:17 PMCID:PMC3942264

[26] Morgan R,Shears L,Pettengell R.Antagonism of HOX/PBX dimer formation blocks the in vivo proliferation of melanoma..Cancer Res2007;67:5806-13

[27] Morgan R,Gray S,Tabi Z,Harrington KJ.HOX transcription factors are potential targets and markers in malignant mesothelioma..BMC Cancer2015;16:85 PMCID:PMC4750173

[28] Morgan R,Harrington KJ,Pandha HS.Targeting HOX and PBX transcription factors in ovarian cancer..BMC Cancer2010;10:89 PMCID:PMC2846885

[29] Plowright L,Pandha HS.HOX transcription factors are potential therapeutic targets in non-small-cell lung cancer (targeting HOX genes in lung cancer)..Br J Cancer2009;100:470-5 PMCID:PMC2658540

[30] Ducruet AP,Wipf P.Dual specificity protein phosphatases: therapeutic targets for cancer and Alzheimer's disease..Annu Rev Pharmacol Toxicol2005;45:725-50

[31] Eichhorst ST,Li-Weber M,Angel P.A novel AP-1 element in the CD95 ligand promoter is required for induction of apoptosis in hepatocellular carcinoma cells upon treatment with anticancer drugs..Mol Cell Biol2000;20:7826-37 PMCID:PMC86378

[32] Grimm C,Behrens A,Wagner EF.AP-1 mediated retinal photoreceptor apoptosis is independent of N-terminal phosphorylation of c-Jun..Cell Death Differ2001;8:859-67

[33] Hafezi F,Wenzel A,Yaniv M.Retinal photoreceptors are apoptosis-competent in the absence of JunD/AP-1..Cell Death Differ1999;6:934-6

[34] Kasibhatla S,Genestier L,Mahboubi A.DNA damaging agents induce expression of Fas ligand and subsequent apoptosis in T lymphocytes via the activation of NF-kappa B and AP-1..Mol Cell1998;1:543-51

[35] Kolbus A,Schreiber M,Wagner EF.c-Jun-dependent CD95-L expression is a rate-limiting step in the induction of apoptosis by alkylating agents..Mol Cell Biol2000;20:575-82 PMCID:PMC85135

[36] Rubin E,Zhu T,Chen H,Pandita RK,Ha HC,Hanakahi LA,Sukumar S.A role for the HOXB7 homeodomain protein in DNA repair..Cancer Res2007;67:1527-35

[37] Gabellini D,Vodermaier HC,Giacca M,Riva S.Early mitotic degradation of the homeoprotein HOXC10 is potentially linked to cell cycle progression..EMBO J2003;22:3715-24 PMCID:PMC165610

[38] Miller GJ,van Bokhoven A,Werahera PN,Lucia MS.Aberrant HOXC expression accompanies the malignant phenotype in human prostate..Cancer Res2003;63:5879-88

[39] Waltregny D,Clausse N,Castronovo V.Overexpression of the homeobox gene HOXC8 in human prostate cancer correlates with loss of tumor differentiation..Prostate2002;50:162-9

[40] Hamid AR,Smit F,van Rijt-van de Westerlo C,van Leenders GJ,Schalken JA.The role of HOXC6 in prostate cancer development..Prostate2015;75:1868-76

[41] Van Neste L,Dijkstra S,Cornel EB,de Jong H,Smit FP,Leyten GH,Vergunst H,Knipscheer BC,Mulders PF,Van Criekinge W.Detection of high-grade prostate cancer using a urinary molecular biomarker-based risk score..Eur Urol2016;70:740-8

[42] Jung C,Lee SJ,Jeng MH.HOXB13 homeodomain protein suppresses the growth of prostate cancer cells by the negative regulation of T-cell factor 4..Cancer Res2004;64:3046-51

[43] Jung C,Zhang HJ,Jeng MH.HOXB13 induces growth suppression of prostate cancer cells as a repressor of hormone-activated androgen receptor signaling..Cancer Res2004;64:9185-92

[44] Kim YR,Park RY,Kang TW,Choi C,Nam KI,Jung C.HOXB13 promotes androgen independent growth of LNCaP prostate cancer cells by the activation of E2F signaling..Mol Cancer2010;9:124 PMCID:PMC2890607

[45] Ewing CM,Lange EM,Robbins CM,Wiley KE,Johng D,Bizon C,Gielzak M,Shanmugam V,Sinari S,Zheng SL,Montie JE,Carpten JD,Cooney KA.Germline mutations in HOXB13 and prostate-cancer risk..N Engl J Med2012;366:141-9 PMCID:PMC3779870

[46] Xu J,Lu L,Wang Z,Cannon-Albright LA,Camp NJ,Zuhlke KA,Ostrander EA,Isaacs SD,Maier C,Vogel W,Wahlfors T,Schaid D,DeRycke MS,Cussenot O,Grönberg H,Easton D,Whittemore AS,Giles GG,Severi G,Mandal D,Foulkes WD,Mahle L,Powell I,Carpten JD,Cooney KA.HOXB13 is a susceptibility gene for prostate cancer: results from the International Consortium for Prostate Cancer Genetics (ICPCG)..Hum Genet2013;132:5-14 PMCID:PMC3535370

[47] Lin X,Chen Z,Ye D,Wang X,Chen Z,Wang M,He D,Gao X,Wang G,Wang G,Jiao Y,Ou-Yang J,Zhu Y,Zhang Z,Wu Q,Turner AR,Na R,Lu D,Sun J,Zheng SL,Sun Y.A novel germline mutation in HOXB13 is associated with prostate cancer risk in Chinese men..Prostate2013;73:169-75 PMCID:PMC3755486

[48] Cardoso M,Paulo P.Oncogenic mechanisms of HOXB13 missense mutations in prostate carcinogenesis..Oncoscience2016;3:288-96 PMCID:PMC5116946

[49] Kim YR,To PK,Cho YS,Kim MS.HOXB13-mediated suppression of p21WAF1/CIP1 regulates JNK/c-Jun signaling in prostate cancer cells..Oncol Rep2016;35:2011-6

[50] Huang Q,Gao P,Yang Y,Vaisanen MR,Annala M,Egevad LA,Lin R,Nykter M,Wiklund F,Visakorpi T,Taipale J.A prostate cancer susceptibility allele at 6q22 increases RFX6 expression by modulating HOXB13 chromatin binding..Nat Genet2014;46:126-35

[51] Kim IJ,Jeong T,Jung C.HOXB13 regulates the prostate-derived Ets factor: implications for prostate cancer cell invasion..Int J Oncol2014;45:869-76

[52] Kim YR,Kang TW,Kim KK,Nam KI.HOXB13 downregulates intracellular zinc and increases NF-kappaB signaling to promote prostate cancer metastasis..Oncogene2014;33:4558-67

[53] Gong Y,Oh WK.Roles of matrix metalloproteinases and their natural inhibitors in prostate cancer progression..Cancers (Basel)2014;6:1298-327 PMCID:PMC4190542

[54] Chambers AF.Changing views of the role of matrix metalloproteinases in metastasis..J Natl Cancer Inst1997;89:1260-70

[55] Lokeshwar BL,Block NL.Secretion of matrix metalloproteinases and their inhibitors (tissue inhibitor of metalloproteinases) by human prostate in explant cultures: reduced tissue inhibitor of metalloproteinase secretion by malignant tissues..Cancer Res1993;53:4493-8

[56] Itoh T,Yoshida H,Nishimoto H.Reduced angiogenesis and tumor progression in gelatinase A-deficient mice..Cancer Res1998;58:1048-51

[57] Pruett ND,Zhang J,Kern MJ,Majesky MW.Changing topographic Hox expression in blood vessels results in regionally distinct vessel wall remodeling..Biol Open2012;1:430-5 PMCID:PMC3507213

[58] Care A,Meccia E,Parenza M,Peschle C.HOXB7: a key factor for tumor-associated angiogenic switch..Cancer Res2001;61:6532-9

[59] Aalinkeel R,Sufrin G,Chadha KC,Schwartz SA.Gene expression of angiogenic factors correlates with metastatic potential of prostate cancer cells..Cancer Res2004;64:5311-21

[60] Aalinkeel R,Reynolds JL,Mahajan SD,Schwartz SA.Overexpression of MMP-9 contributes to invasiveness of prostate cancer cell line LNCaP..Immunol Invest2011;40:447-64

[61] Nalla AK,Gondi CS,Rao JS.Targeting MMP-9, uPAR, and cathepsin B inhibits invasion, migration and activates apoptosis in prostate cancer cells..Cancer Gene Ther2010;17:599-613 PMCID:PMC2919627

[62] Mace KA,Myers C,Boudreau N.HOXA3 induces cell migration in endothelial and epithelial cells promoting angiogenesis and wound repair..J Cell Sci2005;118:2567-77

[63] Wang H,Shen D,Huang J,Sun Y.HOXA1 enhances the cell proliferation, invasion and metastasis of prostate cancer cells..Oncol Rep2015;34:1203-10

[64] Li XY,Yana I,Weiss SJ.Molecular dissection of the structural machinery underlying the tissue-invasive activity of membrane type-1 matrix metalloproteinase..Mol Biol Cell2008;19:3221-33 PMCID:PMC2488283

[65] Jennbacken K,Welen K,Damber JE.Prostate cancer progression into androgen independency is associated with alterations in cell adhesion and invasivity..Prostate2006;66:1631-40

[66] Wang X,Slaton JW,Ewing SL.Increased aggressiveness of human prostate PC-3 tumor cells expressing cell surface localized membrane type-1 matrix metalloproteinase (MT1-MMP)..J Androl2009;30:259-74

[67] Bonfil RD,Trindade Filho JC,Osenkowski P,Yamamoto H,Zhao H,Vessella RL,Cher ML.Prostate cancer-associated membrane type 1-matrix metalloproteinase: a pivotal role in bone response and intraosseous tumor growth..Am J Pathol2007;170:2100-11 PMCID:PMC1899437

[68] Chen J,Xu D,Gao Y.Aquaporin 3 promotes prostate cancer cell motility and invasion via extracellular signal-regulated kinase 1/2-mediated matrix metalloproteinase-3 secretion..Mol Med Rep2015;11:2882-8

[69] Slavin S,Da J,Miyamoto H,Guancial E.Estrogen receptor alpha in cancer-associated fibroblasts suppresses prostate cancer invasion via modulation of thrombospondin 2 and matrix metalloproteinase 3..Carcinogenesis2014;35:1301-9 PMCID:PMC4043239

[70] Zhang L,Zhao D,Guo B,Liang Z,Fang X.Inhibition of tumor growth and induction of apoptosis in prostate cancer cell lines by overexpression of tissue inhibitor of matrix metalloproteinase-3..Cancer Gene Ther2010;17:171-9

[71] Zhu F,Li J.Eotaxin-1 promotes prostate cancer cell invasion via activation of the CCR3-ERK pathway and upregulation of MMP-3 expression..Oncol Rep2014;31:2049-54

[72] Srivastava P,Mittal RD.Impact of MMP-3 and TIMP-3 gene polymorphisms on prostate cancer susceptibility in North Indian cohort..Gene2013;530:273-7

[73] Kalluri R.The basics of epithelial-mesenchymal transition..J Clin Invest2009;119:1420-8 PMCID:PMC2689101

[74] Grant CM.Epithelial mesenchymal transition (EMT) in prostate growth and tumor progression..Transl Androl Urol2013;2:202-11 PMCID:PMC4208065

[75] Shaoqiang C,Yang L,Lina Z,Qingyuan Z.Expression of HOXD3 correlates with shorter survival in patients with invasive breast cancer..Clin Exp Metastasis2013;30:155-63

[76] Brooks PC,Rosenfeld M,Hu T,Cheresh DA.Integrin alpha v beta 3 antagonists promote tumor regression by inducing apoptosis of angiogenic blood vessels..Cell1994;79:1157-64

[77] Pidgeon GP,Cai YL,Honn KV.Overexpression of platelet-type 12-lipoxygenase promotes tumor cell survival by enhancing alpha(v)beta(3) and alpha(v)beta(5) integrin expression..Cancer Res2003;63:4258-67

[78] Teitelbaum SL.Osteoclasts and integrins..Ann N Y Acad Sci2006;1068:95-9

[79] Dresner-Pollak R.Blockade of osteoclast-mediated bone resorption through occupancy of the integrin receptor: a potential approach to the therapy of osteoporosis..J Cell Biochem1994;56:323-30

[80] Rosenthal MA,Rolland F,Xue L,Mehta A,He W.Evaluation of the safety, pharmacokinetics and treatment effects of an alpha(nu)beta(3) integrin inhibitor on bone turnover and disease activity in men with hormone-refractory prostate cancer and bone metastases..Asia Pac J Clin Oncol2010;6:42-8

[81] Jayson GC,Ellis LM.Antiangiogenic therapy in oncology: current status and future directions..Lancet2016;388:518-29

[82] Boudreau NJ.The homeobox transcription factor Hox D3 promotes integrin alpha5beta1 expression and function during angiogenesis..J Biol Chem2004;279:4862-8

[83] Arderiu G,Chen A,East L.HoxA5 stabilizes adherens junctions via increased Akt1..Cell Adh Migr2007;1:185-95 PMCID:PMC2634105

[84] Rhoads K,Charboneau A,Hoffman W.A role for Hox A5 in regulating angiogenesis and vascular patterning..Lymphat Res Biol2005;3:240-52

[85] Care A,Meccia E,Stoppacciaro A,Peschle C.HOXB7 constitutively activates basic fibroblast growth factor in melanomas..Mol Cell Biol1996;16:4842-51 PMCID:PMC231486

[86] Matsuo M,Koizumi K,Saiki I.Tumour-derived fibroblast growth factor-2 exerts lymphangiogenic effects through Akt/mTOR/p70S6kinase pathway in rat lymphatic endothelial cells..Eur J Cancer2007;43:1748-54

[87] Huang S,Mian B,McCarty M,Gudas JM.Fully humanized neutralizing antibodies to interleukin-8 (ABX-IL8) inhibit angiogenesis, tumor growth, and metastasis of human melanoma..Am J Pathol2002;161:125-34

[88] Martin D,Gutkind JS.CXCL8/IL8 stimulates vascular endothelial growth factor (VEGF) expression and the autocrine activation of VEGFR2 in endothelial cells by activating NFkappaB through the CBM (Carma3/Bcl10/Malt1) complex..J Biol Chem2009;284:6038-42 PMCID:PMC2649103

[89] Zabaleta J,Lin HY,Hall MC,Clark PE,Ochoa AC.Cytokine genetic polymorphisms and prostate cancer aggressiveness..Carcinogenesis2009;30:1358-62 PMCID:PMC2718072

[90] Carbone C,Piro G,Cataldo I,Mina MM,Sbarbati A,Tortora G.Combined inhibition of IL1, CXCR1/2, and TGFbeta signaling pathways modulates in-vivo resistance to anti-VEGF treatment..Anticancer Drugs2016;27:29-40

[91] Wei ZW,Wu Y,Xiang Z,Brekken RA,He YL.CXCL1 promotes tumor growth through VEGF pathway activation and is associated with inferior survival in gastric cancer..Cancer Lett2015;359:335-43

[92] Wilson C,Worthington J,Maxwell P,Johnston PG,Wilson RH,Waugh DJ.Dexamethasone potentiates the antiangiogenic activity of docetaxel in castration-resistant prostate cancer..Br J Cancer2008;99:2054-64 PMCID:PMC2607236

[93] Kuo PL,Hung SH.CXCL1/GROalpha increases cell migration and invasion of prostate cancer by decreasing fibulin-1 expression through NF-kappaB/HDAC1 epigenetic regulation..Carcinogenesis2012;33:2477-87

[94] Pecot CV,Yang D,Ivan C,Wu S,Shah MY,Bottsford-Miller J,Kim SB,Gonzalez-Villasana V,Zand B,Mangala LS,Dalton HJ,Wen Y,Baggerly KA,Ram PT,Kundra V,Ali-Fehmi R,Massion PP,Lopez-Berestein G,Sood AK.Tumour angiogenesis regulation by the miR-200 family..Nat Commun2013;4:2427 PMCID:PMC3904438

[95] Dumont DJ,Fong GH,Gertsenstein M,Breitman ML.Dominant-negative and targeted null mutations in the endothelial receptor tyrosine kinase, tek, reveal a critical role in vasculogenesis of the embryo..Genes Dev1994;8:1897-909

[96] Sato TN,Deutsch U,Fujiwara Y,Gridley T,Risau W.Distinct roles of the receptor tyrosine kinases Tie-1 and Tie-2 in blood vessel formation..Nature1995;376:70-4

[97] Suri C,Patan S,Maisonpierre PC,Sato TN.Requisite role of angiopoietin-1, a ligand for the TIE2 receptor, during embryonic angiogenesis..Cell1996;87:1171-80

[98] Satoh N,Kinugasa Y.Angiopoietin-1 alters tumor growth by stabilizing blood vessels or by promoting angiogenesis..Cancer Sci2008;99:2373-9

[99] Rossig L,Bruhl T,Heeschen C,Sasaki K,Diehl F,Potente M,Zanetta L,Zeiher AM.Histone deacetylase activity is essential for the expression of HoxA9 and for endothelial commitment of progenitor cells..J Exp Med2005;201:1825-35 PMCID:PMC2213253

[100] Boudreau N,Srebrow A,Cheresh DA.Induction of the angiogenic phenotype by Hox D3..J Cell Biol1997;139:257-64 PMCID:PMC2139816

[101] Wheler JJ,Falchook GS,Fu S,Tsimberidou AM,Hong DS,Piha-Paul SA,Garcia-Manero G.Phase I study of anti-VEGF monoclonal antibody bevacizumab and histone deacetylase inhibitor valproic acid in patients with advanced cancers..Cancer Chemother Pharmacol2014;73:495-501 PMCID:PMC4148903

[102] Devy L,Grignet-Debrus C,Masson V,Gils A,Carmeliet P,Noel A.The pro- or antiangiogenic effect of plasminogen activator inhibitor 1 is dose dependent..FASEB J2002;16:147-54

[103] Montuori N.Role of uPA/uPAR in the modulation of angiogenesis..Chem Immunol Allergy2014;99:105-22

[104] Traktuev DO,Shevelev AA,Stepanova VV,Rahmat-Zade TM,Tkachuk VA,Parfyonova YV.Urokinase gene transfer augments angiogenesis in ischemic skeletal and myocardial muscle..Mol Ther2007;15:1939-46

[105] Cubellis MV,Cassani G.Binding of single-chain prourokinase to the urokinase receptor of human U937 cells..J Biol Chem1986;261:15819-22

[106] Kwak SH,Bdeir K,Park JS,Idell S,Abraham E.The kringle domain of urokinase-type plasminogen activator potentiates LPS-induced neutrophil activation through interaction with {alpha}V{beta}3 integrins..J Leukoc Biol2005;78:937-45

[107] Mazar AP,Goldfarb RH.The urokinase plasminogen activator system in cancer: implications for tumor angiogenesis and metastasis..Angiogenesis1999;3:15-32

[108] Nykjaer A,Cohen RL,Garni-Wagner BA,3rd,Gliemann J.Regions involved in binding of urokinase-type-1 inhibitor complex and pro-urokinase to the endocytic alpha 2-macroglobulin receptor/low density lipoprotein receptor-related protein. Evidence that the urokinase receptor protects pro-urokinase against binding to the endocytic receptor..J Biol Chem1994;269:25668-76

[109] Pluskota E,Bdeir K,Plow EF.Integrin alphaMbeta2 orchestrates and accelerates plasminogen activation and fibrinolysis by neutrophils..J Biol Chem2004;279:18063-72

[110] Tarui T,Majumdar M,Takagi J,Bdeir K,Yarovoi SV,Takada Y.Direct interaction of the kringle domain of urokinase-type plasminogen activator (uPA) and integrin alpha v beta 3 induces signal transduction and enhances plasminogen activation..Thromb Haemost2006;95:524-34

[111] Miles LA,Griffin JH.A comparison of the abilities of plasma kallikrein, beta-Factor XIIa, Factor XIa and urokinase to activate plasminogen..Thromb Res1983;29:407-17

[112] Peltz SW,Mangel WF.Positive regulation of activation of plasminogen by urokinase: differences in Km for (glutamic acid)-plasminogen and lysine-plasminogen and effect of certain alpha, omega-amino acids..Biochemistry1982;21:2798-804

[113] Baramova EN,Remacle A,Krell HW,Noel A.Involvement of PA/plasmin system in the processing of pro-MMP-9 and in the second step of pro-MMP-2 activation..FEBS Lett1997;405:157-62

[114] Makowski GS.Binding of latent matrix metalloproteinase 9 to fibrin: activation via a plasmin-dependent pathway..Inflammation1998;22:287-305

[115] Matrisian LM.The matrix-degrading metalloproteinases..Bioessays1992;14:455-63

[116] Okumura Y,Seiki M.Proteolytic activation of the precursor of membrane type 1 matrix metalloproteinase by human plasmin. A possible cell surface activator..FEBS Lett1997;402:181-4

[117] Alexander RA,Mihaly-Bison J,Sunzenauer S,Schutz GJ,Breuss JM.VEGF-induced endothelial cell migration requires urokinase receptor (uPAR)-dependent integrin redistribution..Cardiovasc Res2012;94:125-35

[118] Estreicher A,Carpentier JL,Vassalli JD.The receptor for urokinase type plasminogen activator polarizes expression of the protease to the leading edge of migrating monocytes and promotes degradation of enzyme inhibitor complexes..J Cell Biol1990;111:783-92

[119] Prager GW,Steurer S,Mihaly J,Stockinger H.Vascular endothelial growth factor receptor-2-induced initial endothelial cell migration depends on the presence of the urokinase receptor..Circ Res2004;94:1562-70

[120] Ferrara N.Binding to the extracellular matrix and proteolytic processing: two key mechanisms regulating vascular endothelial growth factor action..Mol Biol Cell2010;21:687-90 PMCID:PMC2828956

[121] Matsuno H,Yoshimi N,Hara A,Okada K,Matsuo O.Lack of alpha2-antiplasmin promotes pulmonary heart failure via overrelease of VEGF after acute myocardial infarction..Blood2002;100:2487-93

[122] Park JE,Ferrara N.The vascular endothelial growth factor (VEGF) isoforms: differential deposition into the subepithelial extracellular matrix and bioactivity of extracellular matrix-bound VEGF..Mol Biol Cell1993;4:1317-26 PMCID:PMC275767

[123] Koolwijk P,de Vree WJ,Weich HA,van Hinsbergh VW.Cooperative effect of TNFalpha, bFGF, and VEGF on the formation of tubular structures of human microvascular endothelial cells in a fibrin matrix. Role of urokinase activity..J Cell Biol1996;132:1177-88

[124] Saksela O.Release of basic fibroblast growth factor-heparan sulfate complexes from endothelial cells by plasminogen activator-mediated proteolytic activity..J Cell Biol1990;110:767-75

[125] Stepanova V,Kuo A,Tkachuk S,Bdeir K,Marks MS,Tkachuk VA,Cines DB.Nuclear translocation of urokinase-type plasminogen activator..Blood2008;112:100-10 PMCID:PMC2435680